These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2448307)

  • 1. Interaction of tetrandrine with slowly inactivating calcium channels. Characterization of calcium channel modulation by an alkaloid of Chinese medicinal herb origin.
    King VF; Garcia ML; Himmel D; Reuben JP; Lam YK; Pan JX; Han GQ; Kaczorowski GJ
    J Biol Chem; 1988 Feb; 263(5):2238-44. PubMed ID: 2448307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bis(benzylisoquinoline) analogs of tetrandrine block L-type calcium channels: evidence for interaction at the diltiazem-binding site.
    Felix JP; King VF; Shevell JL; Garcia ML; Kaczorowski GJ; Bick IR; Slaughter RS
    Biochemistry; 1992 Dec; 31(47):11793-800. PubMed ID: 1332772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of Ca2+ entry blockers to cardiac sarcolemmal membrane vesicles. Characterization of diltiazem-binding sites and their interaction with dihydropyridine and aralkylamine receptors.
    Garcia ML; King VF; Siegl PK; Reuben JP; Kaczorowski GJ
    J Biol Chem; 1986 Jun; 261(18):8146-57. PubMed ID: 2424894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of DPI 201-106, a novel cardiotonic agent, with cardiac calcium channels.
    Siegl PK; Garcia ML; King VF; Scott AL; Morgan G; Kaczorowski GJ
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Dec; 338(6):684-91. PubMed ID: 2854216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substituted diphenylbutylpiperidines bind to a unique high affinity site on the L-type calcium channel. Evidence for a fourth site in the cardiac calcium entry blocker receptor complex.
    King VF; Garcia ML; Shevell JL; Slaughter RS; Kaczorowski GJ
    J Biol Chem; 1989 Apr; 264(10):5633-41. PubMed ID: 2538426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiloride analogs inhibit L-type calcium channels and display calcium entry blocker activity.
    Garcia ML; King VF; Shevell JL; Slaughter RS; Suarez-Kurtz G; Winquist RJ; Kaczorowski GJ
    J Biol Chem; 1990 Mar; 265(7):3763-71. PubMed ID: 2154487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetrandrine inhibits both T and L calcium channel currents in ventricular cells.
    Liu QY; Karpinski E; Pang PK
    J Cardiovasc Pharmacol; 1992 Oct; 20(4):513-9. PubMed ID: 1280704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetrandrine: a new ligand to block voltage-dependent Ca2+ and Ca(+)-activated K+ channels.
    Wang G; Lemos JR
    Life Sci; 1995; 56(5):295-306. PubMed ID: 7837929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrandrine and related bis-benzylisoquinoline alkaloids from medicinal herbs: cardiovascular effects and mechanisms of action.
    Kwan CY; Achike FI
    Acta Pharmacol Sin; 2002 Dec; 23(12):1057-68. PubMed ID: 12466042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking T-type calcium channels with tetrandrine inhibits steroidogenesis in bovine adrenal glomerulosa cells.
    Rossier MF; Python CP; Capponi AM; Schlegel W; Kwan CY; Vallotton MB
    Endocrinology; 1993 Mar; 132(3):1035-43. PubMed ID: 8382595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the calcium entry blocker receptor complex in cardiac sarcolemmal membrane vesicles.
    Kaczorowski GJ; Garcia ML; King VF
    Prog Clin Biol Res; 1988; 252():29-34. PubMed ID: 2450371
    [No Abstract]   [Full Text] [Related]  

  • 12. Blockade of voltage-operated calcium channels, increase in spontaneous catecholamine release and elevation of intracellular calcium levels in bovine chromaffin cells by the plant alkaloid tetrandrine.
    Bickmeyer U; Weinsberg F; Müller E; Wiegand H
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Apr; 357(4):441-5. PubMed ID: 9606031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation of calcium channels from cardiac sarcolemmal membrane vesicles into planar lipid bilayers.
    Ehrlich BE; Schen CR; Garcia ML; Kaczorowski GJ
    Proc Natl Acad Sci U S A; 1986 Jan; 83(1):193-7. PubMed ID: 2417238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive heterotropic allosteric regulators of dihydropyridine binding increase the Ca2+ affinity of the L-type Ca2+ channel. Stereoselective reversal by the novel Ca2+ antagonist BM 20.1140.
    Staudinger R; Knaus HG; Glossmann H
    J Biol Chem; 1991 Jun; 266(17):10787-95. PubMed ID: 1645709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of verapamil binding sites in cardiac membrane vesicles.
    Garcia ML; Trumble MJ; Reuben JP; Kaczorowski GJ
    J Biol Chem; 1984 Dec; 259(24):15013-6. PubMed ID: 6096353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of vascular relaxation by thaligrisine: functional and binding assays.
    Tur R; Magraner J; Catret M; Elorriaga M; Ivorra MD; D'Ocon P; Bermejo A; Cabedo N; Cortes D; Anselmi E
    Life Sci; 2000 Aug; 67(13):1535-48. PubMed ID: 10983849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetrandrine: a novel calcium channel antagonist inhibits type I calcium channels in neuroblastoma cells.
    Liu QY; Karpinski E; Rao MR; Pang PK
    Neuropharmacology; 1991 Dec; 30(12A):1325-31. PubMed ID: 1787886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tetrandrine on calcium channel currents of bovine chromaffin cells.
    Weinsberg F; Bickmeyer U; Wiegand H
    Neuropharmacology; 1994 Jul; 33(7):885-90. PubMed ID: 7969809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydropyridine binding and Ca(2+)-channel characterization in clonal calcitonin-secreting cells.
    Krautwurst D; Scherübl H; Kleppisch T; Hescheler J; Schultz G
    Biochem J; 1993 Feb; 289 ( Pt 3)(Pt 3):659-65. PubMed ID: 8382045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temperature-dependent regulation of d-cis-[3H]diltiazem binding to Ca2+ channels by 1,4-dihydropyridine channel agonists and antagonists.
    Glossmann H; Linn T; Rombusch M; Ferry DR
    FEBS Lett; 1983 Aug; 160(1-2):226-32. PubMed ID: 6309565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.